Send to:

Choose Destination
See comment in PubMed Commons below
Curr Pathobiol Rep. 2013 Mar;1(1):53-62.

MicroRNAs in Liver Health and Disease.

Author information

  • 1Department of Molecular and Cellular Biochemistry, The Ohio State University, Columbus, OH 43210, USA. Comprehensive Cancer Center, The Ohio State University, 420 West 12th Avenue, 606 TMRF Building, Columbus, OH 43210, USA.


MicroRNAs (miRNAs), a class of short non-coding RNAs, have been studied intensely and extensively in the past decade in every aspect of biological processes, including cell differentiation, proliferation and death. These findings pointed out the pivotal role of miRNA in posttranscriptional control of gene expression in animals and established miRNAs as therapeutic targets for different pathophysiological processes, including liver disease. Here we have discussed the recent advances made in identifying the miRNAs deregulated in different liver diseases such as obesity, hepatitis, alcoholic and nonalcoholic steatohepatitis, cirrhosis and hepatocellular carcinoma, as well as pathophysiological conditions such as developmental abnormality. We have specifically reviewed the role of miRNAs in these diseases and discussed critically potential impacts of these miRNAs as biomarkers and/or therapeutic targets in liver pathobiology in the clinical setting. Finally, we have highlighted the latest techniques or preclinical and/or clinical trials that are being developed to replenish or inhibit the deregulated miRNAs.


CC; Fibrosis; Gene therapy; HCC; Hepatitis; Hepatocellular carcinoma; Liver development; Liver disease; Metabolism; Pathobiology; miRNA; microRNA

Free PMC Article
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Write to the Help Desk